INSTITUT NATIONAL DU CANCER GIP - FR 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000

Ranking timeline:

Project Participation Performance(2020-01-01 - 2022-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 19.678.121 1.349.878 2
2020 0 10.999.659 48.296 1

Networking:

Partners:

Institution:Projects [No]:
ALLEANZA CONTRO IL CANCRO2
ACADEMIC MEDICAL CENTRE AMSTERDAM1
AGENCIA DE QUALITAT I AVALUACIO SANITARIES DE CATALUNYA1
ASTELLAS PHARMA EUROPE BV1
BAYER1
BIOSCI CONSULTING BVBA1
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL1
BUNDESMINISTERIUM FUER BILDUNG UND FORSCHUNG1
CANADIAN INSTITUTES OF HEALTH RESEARCH1
CELGENE MANAGEMENT SARL1
CENTRE D'ETUDE ET DE RECHERCHES VETERINAIRES ET AGROCHIMIQUES1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
DE CLERCQ & PARTNERS1
DEUTSCHES ZENTRUM FUR LUFT UND RAUMFAHRT EV1
ERASMUS UNIVERSITEIT ROTTERDAM1
EUROPEAN CANCER PATIENT COALITION1
EUROPEAN HEMATOLOGY ASSOCIATION1
FONDATION ARC POUR LA RECHERCHE SUR LE CANCER1
FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS1
FONDAZIONE REGIONALE PER LA RICERCA BIOMEDICA1
FONDS DE LA RECHERCHE SCIENTIFIQUE FNRS1
FONDS VOOR WETENSCHAPPELIJK ONDERZOEKVLAANDEREN1
FONDS ZUR FOERDERUNG DER WISSENSCHAFTLICHEN FORSCHUNG1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
FUNDACAO PARA A CIENCIA E A TECNOLOGIA1
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON1
FUNDACIO PRIVADA INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU1
FUNDACION CIENTIFICA DE LA ASOCIACION ESPANOLA CONTRA EL CANCER1
FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON1
FUNDACION PARA EL FOMENTO EN ASTURIAS DE LA INVESTIGACION CIENTIFICA APLICADA Y TECNOLOGIA1
GENIKI GRAMMATIA EREVNAS KAI KAINOTOMIAS1
HOSPICES CIVILS DE LYON1
HOSPITAL CLINIC DE BARCELONA1
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE1
INSTITUT CATALA D'ONCOLOGIA1
INSTITUT CURIE1
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS1
INSTITUT JULES BORDET ASBL1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INSTITUTO DE SALUD CARLOS III1
ISTITUTI FISIOTERAPICI OSPITALIERI1
ISTITUTO EUROPEO DI ONCOLOGIA1
ISTITUTO SUPERIORE DI SANITA1
JANSSEN PHARMACEUTICA NV1
KREFTFORENINGEN1
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN1
MEDIZINISCHE UNIVERSITAET WIEN1
MILTENYI BIOTEC BV & CO KG1
MINISTERO DEL LAVORO DELLA SALUTE E DELLE POLITICHE SOCIALI1
MINISTERO DELL'UNIVERSITA E DELLA RICERCA1
MINISTRY OF HEALTH1
MINISTRY OF SCIENCE AND TECHNOLOGY1
NARODOWE CENTRUM BADAN I ROZWOJU1
NEMZETI KUTATASI FEJLESZTESI ES INNOVACIOS HIVATAL1
NORGES FORSKNINGSRAD1
OSPEDALE PEDIATRICO BAMBINO GESU1
REGIONE TOSCANA1
SIHTASUTUS EESTI TEADUSAGENTUUR1
SLOVENSKA AKADEMIA VIED1
STICHTING KANKERREGISTER FONDATION REGISTRE DU CANCER1
STICHTING VUMC1
TAKEDA PHARMACEUTICALS INTERNATIONAL1
TCURX1
TECHNISCHE UNIVERSITAET MUENCHEN1
THE HEALTH RESEARCH BOARD1
TURKIYE BILIMSEL VE TEKNOLOJIK ARASTIRMA KURUMU1
UNITATEA EXECUTIVA PENTRU FINANTAREA INVATAMANTULUI SUPERIOR A CERCETARII DEZVOLTARII SI INOVARII1
UNIVERSIDAD DE NAVARRA1
UNIVERSITA VITASALUTE SAN RAFFAELE1
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT1
UNIVERSITY COLLEGE LONDON1
VALSTS IZGLITIBAS ATTISTIBAS AGENTURA1

Constancy:

Total number of partners: 74
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 74
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2021-03-01ERA-NET: Sustained collaboration of national and regional programmes in cancer research TRANSCAN-3participant10.949.93631
2021-01-01Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy T2EVOLVEparticipant8.728.18529
2020-01-01NGS diagnostics in 21st century oncology: the best, for all, at all times oncNGSparticipant10.999.65917